Dec 01, 2020 / 03:30PM GMT
Maneka Mirchandaney - Evercore ISI Institutional Equities, Research Division - Analyst
Great. Good morning, everyone. This is Maneka Mirchandaney from the Evercore ISI biotech team. I'm really pleased to be here with Incyte. We've got Hervé, Christiana, Mike and Christine from the team. Thank you all for being here.
Questions and Answers:
Maneka Mirchandaney - Evercore ISI Institutional Equities, Research Division - AnalystAnd maybe to start, can you just give us a quick sense for where Incyte is now? And what the key areas of focus for the company are going to be over the next couple of years?
Herve Hoppenot - Incyte Corporation - Chairman, President & CEO
Okay. Well, good morning. Happy to be here to speak about that. I mean the way we look at -- I mean, it has been a fairly busy year. It was a little bit of a paradox because we were dealing with the COVID situation. And then at the same time, we had like 3 new approvals during the year. We have been in a fairly busy phase of the -- in the life of the
Trustpilot
